主要教育和工作经历： 教育经历: 1. 1981/09 - 1987/07，中山医科大学（临床医学），学士 2. 1994/09 - 1997/12，中山医科大学（肿瘤学），硕士 工作经历: 1. 1987/07-1994/11，中山大学肿瘤防治中心/放疗科，住院医师 2. 1994/11-2002/1，中山大学肿瘤防治中心/放疗科，主治医师 3. 2002/01-2014/12，中山大学肿瘤防治中心/放疗科，副主任医师，兼任放疗门诊区长 4. 2014/12-2017/05，中山大学肿瘤防治中心/放疗科，主任医师，兼任放疗门诊区长 5.2017/05-至今，中山大学附属第一医院/放射治疗科，主任医师、科室主任 社会兼职：广东省医师协会放射治疗医师分会常委 论著（SCI，第一作者/通信作者）： (1) Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma an analysis of a phase III randomized trial.Scientific Reports.(IF=5.578) (2) Development and external validation of nomograms for predicting survival in nasopharyngeal carcinoma patients after definitive radiotherapy. Scientific Reports.(IF=5.578) (3) Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer. (IF=4.889) (4) Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. International Journal of Radiation Oncology Biology Physics. (IF=4.258) (5) Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC. Tumor Biology. (IF=3.611) (6) Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy? BMC Cancer. (IF=3.362 ) (7) Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma. BMC Cancer. (IF=3.362 ) (8) Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study. BMC Cancer. (IF=3.362 ) (9) Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy. Radiation Oncology. (IF= 2.546) (10) Spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma and salivary gland-type carcinomas. Clinical Otolaryngology. (IF=2.113 )